References
- Kane J M, Lieberman J A. Adverse effects of psychotropic drugs. Guilford Press, New York 1992
- Kendell R. Diagnosis and classification of functional psychoses. British Medical Bulletin 1987; 43: 499–513
- Johnstone E C, Crow T J, Frith C D, Owens D G. The Northwick Park ‘functional’ psychosis study: diagnosis and treatment response. Lancet 1988; 2: 119–126
- Tollefson G D, Beasley C M, Tran P V, et al. Olanzapine vs. haloperidol in the treatment of schizophrenia and schizoaf-fective and schizophreniform disorders: results of an international collaborative trial. American Journal of Psychiatry 1997; 154: 457–465
- Ayd F J. Lexicon of psychiatry, neurology and the neuro-sciences. Williams and Wilkins, Baltimore 1995; 446–447
- Kane J, Honigfeld G, Singer J, Meltzer H, the Clozaril Collaborative Study Group. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison vs. chlorpromazine/benztropine. Archives of General Psychiatry 1988; 45: 789–796
- Marder S R, Meibach R C. Risperidone in the treatment of schizophrenia. American Journal of Psychiatry 1994; 151: 825–835
- Kane J M, Woerner M, Safferman A, Pollack S, Lìeberman J. Does clozapine cause tardive dyskinesia?. Journal of Clinical Psychiatry 1993; 54: 327–330
- Tollefson G D, Beasley C M, Tamura R N, Tran P V, Potvin J H. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. American Journal of Psychiatry 1997; 154: 1248–1254